Back

Addressing a complicated problem: can COVID-19 asymptomatic cases be detected and epidemics stopped, when testing is limited and the location of such cases unknown?

Rivas, A. L.; Hoogesteyn, A. L.; Hittner, J.; Fasina, F. O.; van Regenmortel, M. H. V.

2020-11-13 health economics
10.1101/2020.11.10.20223495 medRxiv
Show abstract

Can the COVID-19 pandemic be stopped when the principal disseminators -asymptomatic cases- are not easily observable? This question was addressed exploring the cumulative epidemiologic data reported by 51 countries, up to October 2, 2020. In particular, the validity of test positivity and its inverse (the ratio of tests performed per case detected) to indicate whether asymptomatic cases are being detected and isolated -even when only a minor percentage of the population is tested- was evaluated. By linking test positivity data to the number of COVID-19 related deaths reported per million inhabitants, the research question was answered: countries that expressed a high percentage of test positivity (>5%) reported, on average, 15 times more deaths than countries that exhibited <1% test positivity. It is suggested that such a large difference in outcomes is due to the exponential growth that epidemics may experience when silent (asymptomatic) cases are not detected and, consequently, the disease disseminates. Because temporal and geo-referenced data on test positivity may facilitate cost-effective, site-specific testing policies, it is postulated that the risk of uncontrolled epidemics may be ameliorated when test positivity is investigated.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.